Financial centre

Analyst estimates

Analyst recommendations and contact details
PDF [24 kb]


Y/e 31 March 2009 Y/e 31 March 2010
Institution Last updated EBIT ($m) Benchmark PBT ($m) Benchmark EPS ($c) DPS ($c) EBIT ($m) Benchmark PBT ($m) Benchmark EPS ($c) DPS ($c)
Merrill Lynch Jul-08 1,023 892 64.8 20.3 1,123 1,015 73.5 23.0
UBS Equities Jul-08 1,026 885 64.0 19.1 1,119 997 71.2 21.2
Cazenove Jul-08 971 832 60.5 18.8 1,004 888 63.7 19.8
Deutsche Bank Jun-08 1,001 866 65.3 19.5 1,078 949 71.2 20.2
Morgan Stanley Jul-08 982 832 60.6 20.2 1,101 959 69.5 21.9
Citi Group Jul-08 973 838 60.7 18.6 1,065 951 68.8 21.1
Goldman Sachs Jun-08 1,048 911 65.6 20.7 1,143 1,029 73.9 23.7
Redburn Partners Apr-08 1,017 907 66.3 19.7        
Stephens Inc Jul-08 1,003 873 63.7 16.8 1,126 1,006 72.9 20.2
KBW Jun-08 1,043 905 65.6 20.6 1,126 995 71.9 22.6
ABN Amro Jun-08 979 839 61.1 20.4 997 874 63.5 21.2
Total Consensus 1,006 871 63.5 19.5 1,088 966 70.0 21.5
Max 1,048 911 66.3 20.7 1,143 1,029 73.9 23.7
Min 971 832 60.5 16.8 997 874 63.5 19.8

Where analysts' EBIT and PBT forecasts are prepared on a non-benchmark basis, the above numbers have been adjusted to be consistent with the Experian definitions set out below:

EBIT – EBIT is defined as profit before amortisation of acquisition intangibles, goodwill impairments, charges in respect of the demerger-related equity incentive plans, exceptional items, net financing costs and taxation. It includes the Group's share of associates' pre-tax profit.

Benchmark PBT - Benchmark PBT is defined as profit before amortisation of acquisition intangibles, goodwill impairments, charges in respect of the demerger-related equity incentive plans, exceptional items, financing fair value remeasurements and taxation

The forecasts above have been provided to Experian by a number of registered investment analysts for reproduction on Experian's website and as such, the information is publicly available. The information is provided by Experian for information purposes only and is not intended for trading purposes.

The research presented here is the sole responsibility of the registered investment analysts concerned. Experian does not endorse the research in any way and accepts no liability in respect of it. In particular, Experian makes no warranty or representation as to the accuracy of the research, the reasonableness of any assumptions or projections or the likelihood of achieving the figures set out above. Experian has not commented on or verified any individual forecasts, nor does it intend to do so in future. Experian shall not be liable for any errors in the content of the information, or for any action taken in reliance thereon.

It should be noted that forecasts are by definition forward looking and are therefore subject to risks and uncertainties that may materially affect eventual results. Although Experian will endeavour to procure that the information and projections are kept updated, Experian assumes no obligation to update or revise such information or projections.

Adobe Acrobat Reader icon and link to Adobe website (opens in a new window) This page includes links to documents in Portable Document File (PDF) format. To read PDF documents you may need to download the free Adobe Acrobat Reader. For PDF accessibility help, visit Access Adobe. These links will open in a new browser window.

Top of page